Jim Simons Xtl Biopharmaceuticals LTD Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.13 - $2.91 $49,586 - $67,744	-23,280 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.63 - $4.41 $2,630 - $4,410	1,000 Added 4.49%	23,280 $64,000
Q3 2021 Nov 12, 2021	SELL	$3.43 - $5.2 $51,131 - $77,516	-14,907 Reduced 40.09%	22,280 $98,000
Q2 2021 Aug 13, 2021	SELL	$3.0 - $3.99 $4,839 - $6,435	-1,613 Reduced 4.16%	37,187 $148,000
Q1 2021 May 13, 2021	BUY	$2.89 - $4.15 $55,687 - $79,966	19,269 Added 98.66%	38,800 $129,000
Q4 2020 Feb 10, 2021	BUY	$1.83 - $3.17 $35,741 - $61,913	19,531 New	19,531 $59,000

431K

Ticker XTLB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,449,060
Market Cap $10.2M
Description
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Ye...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.